Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-28

Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis Knee Pain [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of X0002 Spray for pain in osteoarthritis of the knee has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • X0002 Spray

Snippet

Sponsor: Techfields Pharma Co. Ltd | Conditions: Pain Associated With Osteoarthritis of the Knee | Phase 3 | Status: COMPLETED